Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension

Amyloid · Published 2026-06-15 · DOI 10.1080/13506129.2026.2685666

Free full text

Authors (13)

Cécile Cauquil, David Adams, Julian Gillmore, Alejandra Gonzalez-Duarte, Michelle Mezei, Laura Obici, Yoshiki Sekijima, Weizhi Zhao, Katherine Boyle, Prajakta Badri, Marianne Sweetser, Colleen Moffitt, Márcia Waddington Cruz

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Cauquil, C., Adams, D., Gillmore, J., et al. (2026). Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension. Amyloid. https://doi.org/10.1080/13506129.2026.2685666

Related articles